BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 26984186)

  • 1. TRPA1 mediates trigeminal neuropathic pain in mice downstream of monocytes/macrophages and oxidative stress.
    Trevisan G; Benemei S; Materazzi S; De Logu F; De Siena G; Fusi C; Fortes Rossato M; Coppi E; Marone IM; Ferreira J; Geppetti P; Nassini R
    Brain; 2016 May; 139(Pt 5):1361-77. PubMed ID: 26984186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The involvement of the TRPA1 receptor in a mouse model of sympathetically maintained neuropathic pain.
    Pinheiro Fde V; Villarinho JG; Silva CR; Oliveira SM; Pinheiro Kde V; Petri D; Rossato MF; Guerra GP; Trevisan G; Antonello Rubin M; Geppetti P; Ferreira J; André E
    Eur J Pharmacol; 2015 Jan; 747():105-13. PubMed ID: 25498793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nociception in a Progressive Multiple Sclerosis Model in Mice Is Dependent on Spinal TRPA1 Channel Activation.
    Ritter C; Dalenogare DP; de Almeida AS; Pereira VL; Pereira GC; Fialho MFP; Lückemeyer DD; Antoniazzi CT; Kudsi SQ; Ferreira J; Oliveira SM; Trevisan G
    Mol Neurobiol; 2020 May; 57(5):2420-2435. PubMed ID: 32095993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of transient receptor potential ankyrin 1 (TRPA1) on nociception caused by a murine model of breast carcinoma.
    de Almeida AS; Rigo FK; De Prá SD; Milioli AM; Pereira GC; Lückemeyer DD; Antoniazzi CT; Kudsi SQ; Araújo DMPA; Oliveira SM; Ferreira J; Trevisan G
    Pharmacol Res; 2020 Feb; 152():104576. PubMed ID: 31790822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRPA1 and TRPV4 mediate paclitaxel-induced peripheral neuropathy in mice via a glutathione-sensitive mechanism.
    Materazzi S; Fusi C; Benemei S; Pedretti P; Patacchini R; Nilius B; Prenen J; Creminon C; Geppetti P; Nassini R
    Pflugers Arch; 2012 Apr; 463(4):561-9. PubMed ID: 22258694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antinociceptive activity of transient receptor potential channel TRPV1, TRPA1, and TRPM8 antagonists in neurogenic and neuropathic pain models in mice.
    Sałat K; Filipek B
    J Zhejiang Univ Sci B; 2015 Mar; 16(3):167-78. PubMed ID: 25743118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TRPA1 activation mediates nociception behaviors in a mouse model of relapsing-remitting experimental autoimmune encephalomyelitis.
    Dalenogare DP; Theisen MC; Peres DS; Fialho MFP; Lückemeyer DD; Antoniazzi CTD; Kudsi SQ; Ferreira MA; Ritter CDS; Ferreira J; Oliveira SM; Trevisan G
    Exp Neurol; 2020 Jun; 328():113241. PubMed ID: 32045597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TRPA1/NOX in the soma of trigeminal ganglion neurons mediates migraine-related pain of glyceryl trinitrate in mice.
    Marone IM; De Logu F; Nassini R; De Carvalho Goncalves M; Benemei S; Ferreira J; Jain P; Li Puma S; Bunnett NW; Geppetti P; Materazzi S
    Brain; 2018 Aug; 141(8):2312-2328. PubMed ID: 29985973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophages and Schwann cell TRPA1 mediate chronic allodynia in a mouse model of complex regional pain syndrome type I.
    De Logu F; De Prá SD; de David Antoniazzi CT; Kudsi SQ; Ferro PR; Landini L; Rigo FK; de Bem Silveira G; Silveira PCL; Oliveira SM; Marini M; Mattei G; Ferreira J; Geppetti P; Nassini R; Trevisan G
    Brain Behav Immun; 2020 Aug; 88():535-546. PubMed ID: 32315759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel therapeutic strategy to prevent chemotherapy-induced persistent sensory neuropathy by TRPA1 blockade.
    Trevisan G; Materazzi S; Fusi C; Altomare A; Aldini G; Lodovici M; Patacchini R; Geppetti P; Nassini R
    Cancer Res; 2013 May; 73(10):3120-31. PubMed ID: 23477783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidative stress mediates thalidomide-induced pain by targeting peripheral TRPA1 and central TRPV4.
    De Logu F; Trevisan G; Marone IM; Coppi E; Padilha Dalenogare D; Titiz M; Marini M; Landini L; Souza Monteiro de Araujo D; Li Puma S; Materazzi S; De Siena G; Geppetti P; Nassini R
    BMC Biol; 2020 Dec; 18(1):197. PubMed ID: 33317522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxaliplatin elicits mechanical and cold allodynia in rodents via TRPA1 receptor stimulation.
    Nassini R; Gees M; Harrison S; De Siena G; Materazzi S; Moretto N; Failli P; Preti D; Marchetti N; Cavazzini A; Mancini F; Pedretti P; Nilius B; Patacchini R; Geppetti P
    Pain; 2011 Jul; 152(7):1621-1631. PubMed ID: 21481532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Schwann cell TRPA1 mediates neuroinflammation that sustains macrophage-dependent neuropathic pain in mice.
    De Logu F; Nassini R; Materazzi S; Carvalho Gonçalves M; Nosi D; Rossi Degl'Innocenti D; Marone IM; Ferreira J; Li Puma S; Benemei S; Trevisan G; Souza Monteiro de Araújo D; Patacchini R; Bunnett NW; Geppetti P
    Nat Commun; 2017 Dec; 8(1):1887. PubMed ID: 29192190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution and interaction of kinin receptors and dynorphin A in a model of trigeminal neuropathic pain in mice.
    Luiz AP; Schroeder SD; Rae GA; Calixto JB; Chichorro JG
    Neuroscience; 2015 Aug; 300():189-200. PubMed ID: 25982562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transient receptor potential ankyrin 1 (TRPA1) plays a critical role in a mouse model of cancer pain.
    Antoniazzi CTD; Nassini R; Rigo FK; Milioli AM; Bellinaso F; Camponogara C; Silva CR; de Almeida AS; Rossato MF; De Logu F; Oliveira SM; Cunha TM; Geppetti P; Ferreira J; Trevisan G
    Int J Cancer; 2019 Jan; 144(2):355-365. PubMed ID: 30289972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stromal cell-derived CCL2 drives neuropathic pain states through myeloid cell infiltration in injured nerve.
    Van Steenwinckel J; Auvynet C; Sapienza A; Reaux-Le Goazigo A; Combadière C; Melik Parsadaniantz S
    Brain Behav Immun; 2015 Mar; 45():198-210. PubMed ID: 25449579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implication of the chemokine CCL2 in trigeminal nociception and traumatic neuropathic orofacial pain.
    Dauvergne C; Molet J; Reaux-Le Goazigo A; Mauborgne A; Mélik-Parsadaniantz S; Boucher Y; Pohl M
    Eur J Pain; 2014 Mar; 18(3):360-75. PubMed ID: 23918315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antagonism of Transient Receptor Potential Ankyrin Type-1 Channels as a Potential Target for the Treatment of Trigeminal Neuropathic Pain: Study in an Animal Model.
    Demartini C; Greco R; Zanaboni AM; Francesconi O; Nativi C; Tassorelli C; Deseure K
    Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30366396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of TRPV1 and TRPA1 in incisional intraoral and extraoral pain.
    Urata K; Shinoda M; Honda K; Lee J; Maruno M; Ito R; Gionhaku N; Iwata K
    J Dent Res; 2015 Mar; 94(3):446-54. PubMed ID: 25576470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analgesic effects of the novel semicarbazide-sensitive amine oxidase inhibitor SZV 1287 in mouse pain models with neuropathic mechanisms: Involvement of transient receptor potential vanilloid 1 and ankyrin 1 receptors.
    Horváth Á; Tékus V; Bencze N; Szentes N; Scheich B; Bölcskei K; Szőke É; Mócsai A; Tóth-Sarudy É; Mátyus P; Pintér E; Helyes Z
    Pharmacol Res; 2018 May; 131():231-243. PubMed ID: 29438782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.